Skip to main content
Binge EatingBehavioralBehavioral

What this study is

The goal of this controlled trial is to learn whether a brief single-session intervention (SSI) can reduce binge eating symptoms by targeting overvaluation of weight/shape in women with recurrent binge eating.

The main questions it aims to answer are:

  • Does assessment alone reduce binge eating severity and overvaluation of weight/shape compared to a control group undergoing minimal assessment?
  • Does adding a values-based reflection and goal-setting component (the full SHAPE intervention) add benefits beyond the assessment alone?

Researchers will compare three groups:

1. assessment-only, 2. full SHAPE intervention, and 3. minimal assessment control to see if both active conditions outperform the control, and whether the full intervention adds any benefits beyond the assessment itself

Participants will:

  • Complete a semi-structured eating disorder assessment (Eating Disorder Examination)
  • Depending on assignment, also complete a values-based reflection and goal-setting exercise with psychoeducation
  • Complete follow-up assessments evaluating binge eating severity, overvaluation of weight/shape, clinical impairment, binge frequency, and related outcomes.

What's being tested

  • Assessment-only

    Intervention · BEHAVIORAL

    Diagnostic items of the Eating Disorder Examindation (EDE)

  • values-based reflection and goal-setting/action-planning exercises

    Intervention · BEHAVIORAL

    Assessment-only intervention + values-based reflection and goal-setting/action-planning exercises

  • Minimal-Assessment Control

    Intervention · BEHAVIORAL

    Invovles completing only the Intro/Eating Pattern + Bulimic Episodes/Overeating Sections of Eating Disorder Examination (EDE)

Study details

Official title
Testing a Single-session Consultation for Reducing Binge Eating
Sponsor
Taylor Rezeppa
Conditions
Binge Eating · Binge Eating Behaviour · Binge Eating/Loss of Control Eating · Body Image · Body Image Disturbance
Enrolling
56 people
Starts
2025-10
Est. completion
2027-05
Design
Single-blind, randomized, factorial
Record
View on ClinicalTrials.gov ↗